Navigation Links
Inhibiting fatty acids in immune cells decreases atherosclerosis risk
Date:7/23/2010

substance called fatty acid synthase. This enzyme converts dietary sugars into fatty acids in the liver, where it plays an important role in energy metabolism. But fatty acids also are involved in atherosclerosis.

"The plaques that clog arteries contain large amounts of fatty acids," says senior investigator Clay F. Semenkovich, MD. "We engineered mice that are unable to make fatty acid synthase in one of the major cell types that contribute to plaque formation. On a standard Western diet high in fat, the mice had less atherosclerosis than their normal littermates."

Animals can't survive without fatty acid synthase, so mice in this study were able to make the substance in most of their tissues. They couldn't manufacture it, however, in macrophages, a type of white blood cell that surrounds and kills invading microorganisms, removes dead cells from the body and stimulates the action of other immune cells. Macrophages are dispatched in response to injury, infection and inflammation.

Atherosclerosis is the most common cause of heart disease, which is the leading cause of death in the United States. Semenkovich, the Herbert S. Gasser Professor and chief of the Division of Endocrinology, Metabolism and Lipid Research, says doctors tend to concentrate on treating the surrounding risk factors related to atherosclerosis, such as diabetes and high blood pressure, but he says the blockages themselves cause the most serious, life-threatening problems.

"With the current epidemic of obesity and diabetes, people sometimes forget that it's the blockages in the arteries that really kill people," he says. "We've made progress using statin drugs, for example, that lower cholesterol and fight plaque buildup, but a lot of people who take statins still die from cardiovascular disease. We need better therapies."

These mouse experiments suggest targeting fatty acid synthase in macrophages may provide a potential treatment strategy for humans.
'/>"/>

Contact: Jim Dryden
jdryden@wustl.edu
314-286-0110
Washington University School of Medicine
Source:Eurekalert  

Page: 1 2 3 4

Related medicine news :

1. Fatty acid to enhance anticancer drug
2. Researchers Identify 2 Genes Linked to Fatty Liver Disease
3. Studies Detail Possible Benefits of omega-3 Fatty Acids for Dogs With Arthritis
4. The effect of dietary supplements, acids and animal protein on gastrointestinal disorders
5. UCLA scientists create army of tumor-fighting immune cells and watch as they attack cancer
6. New Anti-HIV Weapons Found in Immune System
7. Genetic regulator opens new avenues to AIDS, immune system research
8. Unlocking the Immune System's Response to Infection and Injury
9. Gene Mutations Offer Clues to Autoimmune Disorders
10. How bacteria boost the immune system
11. Immune system helps transplanted stem cells navigate in central nervous system
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Inhibiting fatty acids in immune cells decreases atherosclerosis risk
(Date:7/29/2015)... Estates, IL (PRWEB) , ... July 29, 2015 , ... ... both benefit from two new products on Mercola.com: a vertical “garden tower” and enhanced ... which can be squeezed into small corners on a porch, balcony, or rooftop – ...
(Date:7/29/2015)... ... July 29, 2015 , ... Elizabeth Callahan, M.D., ... to be chosen by the manufacturer to offer and perform Kybella™ ... way to treat and eliminate double chin fat,” Dr. Callahan explained. “Previously this ...
(Date:7/29/2015)... Thomasville, North Carolina (PRWEB) , ... July 29, 2015 , ... ... hammer and nails in an assisted nursing facility, but that’s exactly what was happening ... Frequent visitors to the facility are 3- and 4-year-olds from Kids Only , ...
(Date:7/28/2015)... ... July 29, 2015 , ... Meet ... and other A-Listers, has evolved into a world class millionaires club, according to ... to match successful and attractive people seeking real, meaningful and mutually beneficial relationships ...
(Date:7/28/2015)... ... 29, 2015 , ... City Sports, a specialty sports retailer and a premiere ... Hanaka as CEO. , Hanaka, who has served on the Board of Directors for ... the Highland Consumer Fund has had previous tenures as Chairman and CEO of Golfsmith ...
Breaking Medicine News(10 mins):Health News:Mercola.com Introduces NEW Garden Tower and Enhanced Mineral Solution for Healthy Plants 2Health News:SkinSmart Dermatology is First in Sarasota to Offer Kybella Treatments to Reduce Double Chin Fat 2Health News:SkinSmart Dermatology is First in Sarasota to Offer Kybella Treatments to Reduce Double Chin Fat 3Health News:North Carolina Retirement Community Re-Launches Intergenerational Programming with Onsite Daycare Center 2Health News:North Carolina Retirement Community Re-Launches Intergenerational Programming with Onsite Daycare Center 3Health News:North Carolina Retirement Community Re-Launches Intergenerational Programming with Onsite Daycare Center 4Health News:Meet a Millionaire Announces It’s Not a Sugar Daddy Site, It’s a True Millionaires Club 2Health News:City Sports Names Marty Hanaka CEO 2
... 3 HIV/AIDS drugs, Viraday that needs to be taken just ... three anti-HIV drugs efavirenz 600 mg, tenofovir 300 mg and ... alone effectively treats a HIV infected person, eliminates the need ... it is less burdensome and it can be taken along ...
... drug misoprostol, normally used to treat ulcers, was found ... death of women in developing countries, according// to a ... of Missouri, India's Jawaharlal Nehru Medical College, and the ... in the Oct. 8 issue of Lancet, found misoprostol ...
... at the Launceston General Hospital have developed a revolutionary ... of the LGH Dementia Research Centre George Razay merely ... type of dementia. ,Over 5000 Tasmanians are affected by ... by 2050. ,20 patients, equal number ...
... the intensive care unit previously occupied by ... the odds of acquiring such bacteria.// ... death in hospitals: methicillin-resistant Staphylococcus aureus (MRSA) ... information in the article. Researchers previously found ...
... Poor services are provided by doctors and dentists according ... trust which runs Barrowa€?s Furness General Hospital is rated ... has roundly criticised the NHS services in Cumbria. ... more wide-ranging and tougher than the old hotel-style star ...
... cell is a reservoir of proteins and performs the role of ... none other than the cell nucleus//, which houses the DNA, and ... particular protein is to be manufactured, the command is reproduced verbatim ... like substance, and is carried via pores in the cell nucleus ...
Cached Medicine News:Health News:Ulcer Drug Could Save Lives of Women in Developing Countries 2Health News:Transmission of Antibiotic-Resistant Bacteria Linked to Previous ICU Room Occupants 2Health News:The Living Cell – Manufacturing, Protecting and Thrivin 2
(Date:7/28/2015)... Calif. , July 28, 2015  Nevro ... device company that is providing innovative evidence-based solutions ... the publication of the SENZA-RCT results in the ... Journal of the American Society of Anesthesiologists. ... ground-breaking study that was the first to directly ...
(Date:7/28/2015)...  PD-Rx Pharmaceuticals, Inc., a publicly held corporation, ... with Dobson Technologies, a fully-integrated outsourced IT provider, ... PD-Rx is an Application Service Provider ... Using Dobson Technologies, IaaS solution will allow PD-Rx ... regulatory compliance, and reduce operating expenses.  "The most ...
(Date:7/28/2015)... BIRMINGHAM, Ala. , July 28, 2015   ... butler for surgeons , has just hired John ... and Business Development. John has over 30 years of ... executive roles. Mr. O,Neil,s executive healthcare experience coupled with ... an active surgeon allows Vincari to address the challenges ...
Breaking Medicine Technology:Nevro Announces Publication of SENZA-RCT Results in Anesthesiology 2PD-Rx Partners With Dobson Technologies 2John O'Neil Joins Vincari as Executive Vice President of Strategy and Business Development 2
... Nile Therapeutics, Inc. (Nasdaq: NLTX ), a ... patients, today announced dosing of the first patient in ... subcutaneous cenderitide.  The trial is being conducted pursuant to ... first clinical step towards developing cenderitide as a treatment ...
... -- ShangPharma Corporation ("ShangPharma", NYSE: SHP ) ... on Form 20-F for the year ended December 31, ... (the "SEC"). The annual report can be accessed on ... Relations section. ShangPharma will provide a hard copy of ...
Cached Medicine Technology:Nile Therapeutics Announces Dosing of First Patient in Phase I Study of Cenderitide 2Nile Therapeutics Announces Dosing of First Patient in Phase I Study of Cenderitide 3
Upper arm protection...
Lap pad used to protect pelvic regions...
Light and comfortable thyroid protection. The softest, most comfortable throid collar made. No neck irritating binding....
The front of this apron is tapered for maximum adjustability as needed. We can include a specially designed half-apron to be worn under the full apron for double protection in the abdomen/pelvic cav...
Medicine Products: